Day: September 29, 2023

Infinx Healthcare Recognized as a Sample Vendor for Intelligent Prior Authorization for Second Year in a Row in the Gartner Hype Cycle for U.S. Healthcare Payers, 2023

Gartner Hype Cycle Recognizes Infinx Healthcare as a Sample Vendor for Intelligent Prior AuthorizationNEW YORK, NY / ACCESSWIRE / September...

Zynerba Pharmaceuticals Stockholders Reminded to Tender Shares Before 5:00 PM New York City Time, on Tuesday October 10, 2023

DEVON, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid...

Odronextamab BLA for Treatment of Relapsed/Refractory Follicular Lymphoma (FL) and Diffuse Large B-cell Lymphoma (DLBCL) Accepted for FDA Priority Review

If approved, odronextamab would be the first and only bispecific antibody approved in both FL and DLBCL – the two...

error: Content is protected !!